StemLab Company Profile, Contacts & Intelligence

StemLab Overview

StemLab is a Korean biotech company that is developing therapeutic solutions to treat diseases and injuries that have no alternative cures. In particular, it develops cells that can regenerate the central nervous system tissues based on its cell reprogramming technology that transforms somatic cells into stem cells. Stemlab’s cell reprogramming technology takes fully differentiated cells and reprograms them into neural stem cells, allowing them to obtain the stem cells necessary to create stem cell therapies. It thus avoids the ethical issues concernng embryonic stem cell research. Also, its reprogrammed neural stem cells have expansion capability comparable to neural stem cells derived from pluripotent stem cells. And since StemLab obtains somatic cells through urine, harvesting is much less invasive than using cells obtained using other invasive means. StemLab's technology is backed up with 18 patents for original technology related to stem cell treatments and has three patents for application technology, with another five pending. Its initial clinical programs will involve patients with spinal cord injury (SCI) and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease).

Headquarters

Kr

Website

stemlab.co.kr

Industry

Biotechnology

Founded

2011

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

StemLab Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

StemLab People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

StemLab Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to StemLab

Explore companies in related markets and compare their industry and employee estimates.